MedWorm: Internal Medicine

Elevated tafi linked to behcet disease

MedWire News - Thrombosis — Fri, 16 May 2008 16:19:36 +0100

High levels of thrombin activatable fibrinolysis inhibitor may contribute to the increased risk for thrombosis found in patients with the chronic vasculitis condition Behçet disease, Spanish researchers say. (Source: MedWire News - Thrombosis)

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.

Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention

Future Medicine: Therapy — Fri, 16 May 2008 03:05:58 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 261-263. (Source: Future Medicine: Therapy)

Post-pci thrombogenicity linked to race, gender, ischemia risk

MedWire News - Thrombosis — Fri, 16 May 2008 00:00:00 +0100

Thrombogenicity is significantly influenced by race and gender, say researchers who believe their findings help explain the high risk for recurrent ischemic events in African-American and female percutaneous coronary intervention patients. (Source: MedWire News - Thrombosis)

Endoscopy in barrett’s oesophagus: adherence to standards and neoplasia detection in the community practice versus hospital setting

Journal of Internal Medicine — Thu, 15 May 2008 18:30:47 +0100

Journal of Internal Medicine, Volume 0, Issue 0, Page ???, OnlineEarly Articles. Pohl H, Aschenbeck J, Drossel R, Schröder A, Mayr M, Koch M, Rothe K, Anders M, Voderholzer W, Hoffmann J, Schulz H-J, Liehr R-M, Gottschalk U, Wiedenmann, B, Rösch T (Charité University Hospitals, Humboldt Hospital, and Maria Heimsuchung Hospital, Berlin,... (Source: Journal of Internal Medicine)

Human papillomavirus screening and vaccines for cancer prevention: what is on the horizon?

Future Medicine: Therapy — Thu, 15 May 2008 13:45:23 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 295-303. This perspective aims to look at how the recently licensed human papillomavirus (HPV) vaccines, based on L1 virus-like particles (VLPs), will impact cervical cancer globally, and what remains to be done in this field. The current VLP vaccines protect ... (Source: Future Medicine: Therapy)

Reduction of stroke and all-cause mortality in the very elderly using antihypertensive treatment: results from the hyvet trial

Future Medicine: Therapy — Thu, 15 May 2008 13:45:21 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 351-353. (Source: Future Medicine: Therapy)

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.

The need for actions to effectively prevent cervical cancer: priorities and future directions of eurogin

Future Medicine: Therapy — Thu, 15 May 2008 13:45:19 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 269-272. (Source: Future Medicine: Therapy)

Cross-protection from human papillomavirus 16/18 against types 45 and 31: fact or fancy?

Future Medicine: Therapy — Thu, 15 May 2008 13:45:17 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 265-268. (Source: Future Medicine: Therapy)

Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the phase ii and iii trials

Future Medicine: Therapy — Thu, 15 May 2008 13:45:13 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 313-324. Cervical cancer may be substantially prevented by human papillomavirus (HPV) vaccination. The two most common oncogenic HPV types causing 70% of all cervical cancers are represented in the vaccines by synthetic virus-like particles to the L1 protein of ... (Source: Future Medicine: Therapy)

Hpv and cervical cancer

Future Medicine: Therapy — Thu, 15 May 2008 13:45:11 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 273-277. (Source: Future Medicine: Therapy)

Acknowledgements

Future Medicine: Therapy — Thu, 15 May 2008 13:45:10 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 379-379. (Source: Future Medicine: Therapy)

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.

Sound implementation of human papillomavirus vaccination as a community-randomized trial

Future Medicine: Therapy — Thu, 15 May 2008 13:45:07 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 289-294. To be (most) effective, the very efficacious vaccines against oncogenic human papillomaviruses have to be implemented into national vaccination programs. Inferences from mathematical modeling studies can be made as to the most effective vaccination ... (Source: Future Medicine: Therapy)

Prevention of cervical cancer in developing countries

Future Medicine: Therapy — Thu, 15 May 2008 13:45:02 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 329-338. Despite being a largely preventable disease, cervical cancer remains the most common cancer in women in developing countries, where screening is either limited or nonexistent. The health profile of women living in developing countries is dominated by the ... (Source: Future Medicine: Therapy)

Therapeutic human papillomavirus vaccination

Future Medicine: Therapy — Thu, 15 May 2008 13:45:01 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 339-348. Dysplastic lesions and cancer of the cervix are distinct from most other malignancies in that they harbor foreign antigens derived from human papillomavirus (HPV). The expression of those viral oncogenes is necessary to maintain the cancerous phenotype. ... (Source: Future Medicine: Therapy)

What is the clinical utility of interferon-γ release assays for the diagnosis of tb in high-tb-burden countries?

Future Medicine: Therapy — Thu, 15 May 2008 13:45:00 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 367-375. The advent of interferon-γ release assays (IGRAs) has provided a new insight into the diagnosis and immunology of TB. IGRAs are being widely accepted and marketed in low-TB-burden countries. However, globally, the impact of TB is concentrated in 22 high-... (Source: Future Medicine: Therapy)

Evaluating the potential benefits of universal worldwide human papillomavirus vaccination

Future Medicine: Therapy — Thu, 15 May 2008 13:44:59 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 305-312. Human papillomavirus (HPV) vaccines have opened a new perspective to the prevention of many cancers, mainly cervical cancer, one of the most paradigmatic long-term goals of the cancer-prevention field. For decades, prevention has been, and still is, ... (Source: Future Medicine: Therapy)

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.

Tadalafil in the treatment of lower urinary tract symptoms and erectile dysfunction

Future Medicine: Therapy — Thu, 15 May 2008 13:44:57 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 355-365. In the aging male, erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) are common conditions that have been shown to be related. As life expectancy increases, treatments that target both ED and LUTS will prove increasingly valuable over the ... (Source: Future Medicine: Therapy)

Interview

Future Medicine: Therapy — Thu, 15 May 2008 13:44:57 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 279-281. Dr Kevin Ault is currently an Associate Professor of Gynecology and Obstetrics at Emory University (GA, USA). Dr Ault gained his medical degree at the Indiana University School of Medicine (IN, USA) and is a board-certified gynecologist, with clinical ... (Source: Future Medicine: Therapy)

Efficacy of a prophylactic human papillomavirus vaccine against high-grade vulval and vaginal intraepithelial neoplasia

Future Medicine: Therapy — Thu, 15 May 2008 13:44:56 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 325-328. Vulval and vaginal high-grade intraepithelial neoplasias (VIN 2–3 and VaIN 2–3, respectively) precede vulval and vaginal cancers. The incidence of VIN and VaIN is increasing, and the mean age of women with these lesions is decreasing. Human ... (Source: Future Medicine: Therapy)

Sexual risk assessment is not helpful for recommendations on human papillomavirus vaccination

Future Medicine: Therapy — Thu, 15 May 2008 13:44:54 +0100

Therapy , May 2008, Vol. 5, No. 3, Pages 283-287. (Source: Future Medicine: Therapy)

Desk-bound employees risk vte

MedWire News - Thrombosis — Thu, 15 May 2008 11:02:13 +0100

Long hours working at a desk without a break increases the likelihood for venous thromboembolism, research suggests. (Source: MedWire News - Thrombosis)

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.

Acute interstitial nephritis in association with polymyositis